Clinical Trial Update: Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing daridorexant's impact on sleep, daytime alertness, and smoking-related outcomes; not yet recruiting. Sponsor: Legacy Health Sys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Nicotine Dependence
• Substance Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• QUVIVIQ (daridorexant)

Snippet

Sponsor: Legacy Health System | Conditions: Smoking, Nicotine | Phase 4 | Status: NOT_YET_RECRUITING